Asymptomatic carotid artery stenosis is associated with increased Alzheimer's disease and non-Alzheimer's disease dementia risk

被引:0
作者
Vitali, Francesca [1 ,2 ]
Torrandell-Haro, Georgina [2 ]
Branigan, Gregory [3 ]
Aristizabal, Juan Arias [4 ]
Reiman, Eric [5 ]
Bedrick, Edward J. [6 ]
Brinton, Roberta Diaz [2 ]
Weinkauf, Craig [4 ]
机构
[1] Univ Arizona, Coll Med, Neurol, Tucson, AZ USA
[2] Univ Arizona, Coll Med, Ctr Innovat Brain Sci, Tucson, AZ USA
[3] Univ Arizona, Coll Med, Tucson, AZ USA
[4] Univ Arizona, Coll Med, Dept Surg, Tucson, AZ 85724 USA
[5] Banner Alzheimers Inst, Phoenix, AZ USA
[6] Univ Arizona, Med Ctr, Ctr Biomed Informat & Biostat, Univ Campus, Tucson, AZ USA
关键词
Carotid Stenosis; Neurodegenerative Diseases; Risk Factors; Brain; History; COGNITIVE IMPAIRMENT; VASCULAR CONTRIBUTIONS; ATHEROSCLEROSIS; POPULATION; PREVALENCE; DYSFUNCTION; MANAGEMENT; STROKE;
D O I
10.1136/svn-2024-003164
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background In the absence of a cerebrovascular accident, whether asymptomatic extracranial carotid atherosclerotic disease (aECAD) affects Alzheimer's disease (AD) and non-AD dementia risk is not clear. Understanding whether aECAD is associated with an increased risk for AD is important as it is present in roughly 10% of the population over 60 and could represent a modifiable risk factor for AD and non-AD dementia. Methods This retrospective cohort study analysed Mariner insurance claims. Enrolment criteria included patients aged 55 years or older with at least 5 years of data and no initial dementia diagnosis. Subjects with and without aECAD were evaluated for subsequent AD and non-AD dementia diagnoses. Propensity score matching was performed using confounding factors identified by logistic regression. chi(2) tests and Kaplan-Meier survival curves were used to evaluate the impact of aECAD diagnosis on AD and non-AD dementia risk over time. Results 767 354 patients met enrolment criteria. After propensity score matching, 62 963 subjects with aECAD and 62 963 subjects without ECAD were followed through data records. The aECAD cohort exhibited an increased relative risk of 1.22 (95% CI 1.15 to 1.29, p<0.001) for AD and 1.48 (95% CI 1.38 to 1.59, p<0.001) for non-AD dementias compared with the propensity score-matched cohort without aECAD. The increased AD risk associated with aECAD was evident in patients younger than 75 years old and was less apparent in patients over 75 years of age. Conclusions aECAD is associated with an increased risk of developing AD and non-AD dementias. These findings underscore the need for further prospective evaluation of interactions between aECAD and dementia, with potential implications for change of clinical care in both of these large patient populations.
引用
收藏
页数:8
相关论文
共 50 条
  • [41] RISK FACTORS FOR ALZHEIMER'S DISEASE AND RELATED DEMENTIA DIAGNOSES IN AMERICAN INDIANS
    Carty, Cara L.
    Noonan, Carolyn
    Muller, Clemma
    Saner, Don
    Reiman, Eric M.
    Buchwald, Dedra
    Bell, Ronny A.
    Nelson, Lonnie A.
    ETHNICITY & DISEASE, 2020, 30 (04) : 671 - 680
  • [42] Incidence and lifetime risk of dementia and Alzheimer's disease in a Southern European population
    Lobo, A.
    Lopez-Anton, R.
    Santabarbara, J.
    de-la-Camara, C.
    Ventura, T.
    Quintanilla, M. A.
    Roy, J. F.
    Campayo, A. J.
    Lobo, E.
    Palomo, T.
    Rodriguez-Jimenez, R.
    Saz, P.
    Marcos, G.
    ACTA PSYCHIATRICA SCANDINAVICA, 2011, 124 (05) : 372 - 383
  • [43] Assessment of risk factors for earlier onset of sporadic Alzheimer's disease dementia
    de Oliveira, Fabricio Ferreira
    Ferreira Bertolucci, Paulo Henrique
    Chen, Elizabeth Suchi
    Smith, Marilia Cardoso
    NEUROLOGY INDIA, 2014, 62 (06) : 625 - 630
  • [44] Atrial Fibrillation Is Associated with Cognitive Impairment, All-Cause Dementia, Vascular Dementia, and Alzheimer's Disease: a Systematic Review and Meta-Analysis
    Papanastasiou, Christos A.
    Theochari, Christina A.
    Zareifopoulos, Nikos
    Arfaras-Melainis, Angelos
    Giannakoulas, George
    Karamitsos, Theodoros D.
    Palaiodimos, Leonidas
    Ntaios, George
    Avgerinos, Konstantinos, I
    Kapogiannis, Dimitrios
    Kokkinidis, Damianos G.
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2021, 36 (10) : 3122 - 3135
  • [45] Chromosome 9p21.3 genotype is associated with vascular dementia and Alzheimer's disease
    Emanuele, Enzo
    Lista, Simone
    Ghidoni, Roberta
    Binetti, Giuliano
    Cereda, Cristina
    Benussi, Luisa
    Maletta, Raffaele
    Bruni, Amalia C.
    Politi, Pierluigi
    NEUROBIOLOGY OF AGING, 2011, 32 (07) : 1231 - 1235
  • [46] Can we prevent Alzheimer's disease? Secondary "prevention" trials in Alzheimer's disease
    Carrillo, Maria C.
    Brashear, H. Robert
    Logovinsky, Veronika
    Ryan, J. Michael
    Feldman, Howard H.
    Siemers, Eric R.
    Abushakra, Susan
    Hartley, Dean M.
    Petersen, Ronald C.
    Khachaturian, Ara S.
    Sperling, Reisa A.
    ALZHEIMERS & DEMENTIA, 2013, 9 (02) : 123 - 131
  • [47] Changes in Brain Transcripts Related to Alzheimer's Disease in a Model of HFE Hemochromatosis are not Consistent with Increased Alzheimer's Disease Risk
    Johnstone, Daniel M.
    Graham, Ross M.
    Trinder, Debbie
    Riveros, Carlos
    Olynyk, John K.
    Scott, Rodney J.
    Moscato, Pablo
    Milward, Elizabeth A.
    JOURNAL OF ALZHEIMERS DISEASE, 2012, 30 (04) : 791 - 803
  • [48] Progranulin polymorphism rs5848 is associated with increased risk of Alzheimer's disease
    Sheng, Jinghao
    Su, Liling
    Xu, Zhengping
    Chen, Guangdi
    GENE, 2014, 542 (02) : 141 - 145
  • [49] Non-Alzheimer's contributions to dementia and cognitive resilience in The 90+Study
    Robinson, John L.
    Corrada, Maria M.
    Kovacs, Gabor G.
    Dominique, Myrna
    Caswell, Carrie
    Xie, Sharon X.
    Lee, Virginia M. -Y.
    Kawas, Claudia H.
    Trojanowski, John Q.
    ACTA NEUROPATHOLOGICA, 2018, 136 (03) : 377 - 388
  • [50] Identification of non-Alzheimer's disease tauopathies-related proteins by proteomic analysis
    Yang, Guofeng
    Wang, Luning
    Zhu, Mingwei
    Xu, Dan
    NEUROLOGICAL RESEARCH, 2008, 30 (06) : 613 - 622